Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.

So TakahashiWaku HattaKenta WatanabeTomoyuki KoikeTomohiro ShimadaTakuto HikichiYosuke ToyaIppei TanakaYusuke OnozatoKoichi HamadaDaisuke FukushiKo WatanabeShoichi KayabaHirotaka ItoTatsuya MikamiTomoyuki OikawaYasushi TakahashiYutaka KondoTetsuro YoshimuraTakeharu ShirokiKo NaginoNorihiro HanabataAkira FunakuboDai HirasawaTetsuya OhiraJun NakamuraTomohiro NakamuraNaoki NakayaTakayuki MatsumotoShinsaku FukudaAtsushi MasamuneKatsunori Iijima

Published in: Digestive diseases and sciences (2022)

Additional treatment after ESD in patients with pT1a-MM/pT1b-SM ESCC was not associated with an improved prognosis.

Keyphrases

endoscopic submucosal dissection
combination therapy
replacement therapy